FIGURE 2.
Mechanisms of action for therapeutics with potential benefit in SARS-CoV-2 infection. ACE2, angiotensin converting enzyme 2; TLRs, toll-like receptors; JAK, Janus kinase; NFκB, nuclear factor Kappa B; IL, interleukin; IFN, interferon; TNF, tumor necrosis factor; CP, convalescent plasma; HIG, hyperimmune globulin; CQ, chloroquine; HCQ, hydroxychloroquine; GM-CSF, granulocyote-monocyte colony stimulating factor.